Search for: "ELI LILLY V TEVA PHARMA" Results 61 - 80 of 105
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Oct 2009, 5:13 am
Here is IP Think Tank's weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2011, 11:35 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
25 Jan 2011, 10:58 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
20 Jul 2011, 4:04 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
20 May 2009, 5:18 am
BIO Policy Briefing raises the IP social media question (PatentlyBIOtech) Vietnam: Patentability of medical use claims in Vietnam (RelatIP)   Products Actonel (Risedronic) – US: CAFC affirms Procter & Gamble’s Actonel patent validity; nonobviousness of positional isomer: Procter & Gamble v Teva (Patent Docs) (Patently-O) (SmartBrief) (SmartBrief) (GenericsWeb) Alimta (Pemetrexed) – US: Eli Lilly and Princeton… [read post]
7 Jul 2010, 5:14 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
6 Jul 2010, 6:03 pm by Duncan
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Apr 2010, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 Jan 2010, 3:00 am
(IP Factor) Netherlands: Court of Appeal, The Hague: Costs of procedure : Lundbeck v Tiefenbacher, Centrafarm Services and Ratiopharm (EPLAW) Poland: First judgment on differences between sponsorship and advertising of pharmaceutical product (Class 46) US: USPTO to begin recalculating patent term following Wyeth v Kappos (Patently-O) (Patent Docs) US: CAFC confirms PTO is miscalculating (undercalculating) delays in prosecution and the corresponding patent term adjustment: Wyeth… [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
13 Mar 2009, 2:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
12 Dec 2008, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
13 May 2010, 4:58 pm
(Patent Docs) Evista (Raloxifene) – US: Patent infringement complaint following a Paragraph IV certification: Eli Lilly & Company v. [read post]
25 Nov 2009, 12:00 pm
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Jul 2011, 1:01 am by Marie Louise
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog)   Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]